Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, | AcademicGPT, tlooto

A phase 1/2, single-blind, randomised controlled trial in five trial sites in the UK of a chimpanzee adenovirus-vectored vaccine expressing the SARS-CoV-2 spike protein compared with a meningococcal c (2020), LANCET, Folegatti P. | AcademicGPT, tlooto for Academic and Research